Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study
Peripheral Retinal Imaging Biomarkers for Alzheimer's Disease: A Pilot Study
复制标题
DOI:
10.1159/000487053
复制
发表时间:
2018-01-01
影响因子:
2.1
通讯作者:
Lengyel, Imre
中科院分区:
文献类型:
--
作者:
Csincsik, Lajos;MacGillivray, Thomas J.;Lengyel, Imre
Purpose: To examine whether ultra-widefield (UWF) retinal imaging can identify biomarkers for Alzheimer's disease (AD) and its progression. Methods: Images were taken using a UWF scanning laser ophthalmoscope (Optos P200C AF) to determine phenotypic variations in 59 patients with AD and 48 healthy controls at baseline (BL). All living participants were invited for a follow-up (FU) after 2 years and imaged again (if still able to participate). All participants had blood taken for genotyping at BL. Images were graded for the prevalence of age-related macular degeneration-like pathologies and retinal vascular parameters. Comparison between AD patients and controls was made using the Student t test and the chi(2) test. Results: Analysis at BL revealed a significantly higher prevalence of a hard drusen phenotype in the periphery of AD patients (14/55; 25.4%) compared to controls (2/48; 4.2%) [chi(2) = 9.9, df = 4, p = 0.04]. A markedly increased drusen number was observed at the 2-year FU in patients with AD compared to controls. There was a significant increase in venular width gradient at BL (zone C: 8.425 x 10(-3) +/- 2.865 x 10(-3) vs. 6.375 x 10(-3) +/- 1.532 x 10(-3), p = 0.008; entire image: 8.235 x 10(-3) +/- 2.839 x 10(-3) vs. 6.050 x 10(-3) +/- 1.414 x 10-(3), p = 0.004) and a significant decrease in arterial fractal dimension in AD at BL (entire image: 1.250 +/- 0.086 vs. 1.304 +/- 0.089, p = 0.049) with a trend for both at FU. Conclusions: UWF retinal imaging revealed a significant association between AD and peripheral hard drusen formation and changes to the vasculature beyond the posterior pole, at BL and after clinical progression over 2 years, suggesting that monitoring pathological changes in the peripheral retina might become a valuable tool in AD monitoring. (C) 2018 S. Karger AG, Basel